Anticoagulant drugs with or without proton pump inhibitor and colorectal cancer risk: a population-based, case–control study

BACKGROUND: Low-dose aspirin and clopidogrel have demonstrated potential chemoprevention for colorectal cancer (CRC). Proton-pump inhibitors (PPI) are commonly prescribed with anticoagulation drugs, but the relationship between PPI and CRC is unclear. Moreover, evidence of CRC risk under direct oral...

Descripción completa

Detalles Bibliográficos
Autores principales: Ho, Pei-Huan, Hsiao, Hung-Chun, Chen, Chun-Wei, Chen, Hui-Ming, Lim, Siew-Na, Yeh, Chau-Ting, Kuo, Chia-Jung, Lin, Wey-Ran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9082832/
https://www.ncbi.nlm.nih.gov/pubmed/35534834
http://dx.doi.org/10.1186/s12876-022-02314-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9082832/
https://www.ncbi.nlm.nih.gov/pubmed/35534834
http://dx.doi.org/10.1186/s12876-022-02314-w

Ejemplares similares